<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02735226</url>
  </required_header>
  <id_info>
    <org_study_id>Shanghai Stroke Service System</org_study_id>
    <nct_id>NCT02735226</nct_id>
  </id_info>
  <brief_title>Stroke Prevention and Treatment System in Shanghai: a Network of Public Healthcare of Stroke</brief_title>
  <acronym>SSSS</acronym>
  <official_title>Shanghai Stroke Service System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Stroke Service System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>theTenth People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the Sixth People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ShuGuang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dongfang Hospital Beijing University of Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changzheng Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the Ninth People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Stroke Service System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Shanghai Stroke Service System（4S） has been established as the network of stroke care in&#xD;
      greater Shanghai metropolitan area. The system includes 11 territorial-care hospitals and&#xD;
      their comprehensive stroke unites that provide 24h/7day acute stroke care to a population of&#xD;
      40 million in Shanghai. The System comprised of two consecutive phases, the acute phase that&#xD;
      emphasized on providing thrombolysis, and the in-hospital phase that concentrated on the&#xD;
      effort of recovery and secondary stroke prevention. The novel electronic data aquisition&#xD;
      system provides the contiguous data of clinical care of stroke patients from the acute phase&#xD;
      of management to inpatient rehabilitation. This system has been implemented and maintained as&#xD;
      an ongoing quality of stroke care project that monitored the process of routine stroke care&#xD;
      in Shanghai. It is funded by the Shanghai Municipal Commission of Health and Family Planning.&#xD;
      Our analysis of the project was approved by the Ethics Committee, which agreed that no&#xD;
      written informed consents were needed since the study only was consisted of a&#xD;
      population-based retrospective data analysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of Shanghai stroke service system is to promote and facilitate high quality&#xD;
      standardized stroke care in Shanghai area. The 11 hospitals involved are committed to provide&#xD;
      the best stroke care to their patients. This quality goal consists of two parts: the acute&#xD;
      phase of stroke care and the subsequent care during the hospitalization. To accomplish this&#xD;
      goal, each hospital has organized a multidisciplinary stroke team that will address&#xD;
      day-to-day stroke care. Each hospital provides prioritized neuroimaging service to patients&#xD;
      with acute stroke 24hr per day, 7days per week. A stroke neurologist is on site 24hr per day,&#xD;
      7 days per week in each hospital. This team will follow the guidelines to carry out&#xD;
      standardized secondary stroke prevention once the patient has been admitted.&#xD;
&#xD;
      The stroke clinical pathway is available on line in computers of each hospital. This pathway&#xD;
      can be accessed from hospital computers, or from outside.&#xD;
&#xD;
      Stroke team members in each hospital obtained and entered all data on each stroke patient:&#xD;
      demographics, stroke onset time, onset to thrombolytic time, presenting NIHSS, timing of&#xD;
      diagnostic procedures, treatment strategies, performance of quality measures, comorbidities,&#xD;
      in-hospital mortality, etc. These data are contained in a three-page form, which are embedded&#xD;
      in the electronic health record of each patient.&#xD;
&#xD;
      If ICD-10 stroke codes were entered as the primary discharge diagnoses, the electronic health&#xD;
      record systems would not allow the discharge of the patient until all required documentation&#xD;
      has been completed. The EHR would not allow for any empty fields before it could be closed.&#xD;
      Data quality was assured by automatic feasibility checks. The novel electronic data&#xD;
      acquisition system provides the continuous clinical care data on all stroke patients from&#xD;
      their acute management phase to inpatient rehabilitation or discharge.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>The acute stroke service and treatment provided in Shanghai area</measure>
    <time_frame>5 years</time_frame>
    <description>The phase of acute stroke therapy. Under this category, the acute stroke care specific quality measurement items are:&#xD;
Stroke onset to hospital ER Time&#xD;
Door to CT Time&#xD;
Door to seen by a doctor Time&#xD;
Door to IV TPA Time&#xD;
Door to groin puncture time for IA therapy&#xD;
Door to admission to a hospital bed Time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The secondary prevention of stroke provided after discharge in Shanghai area</measure>
    <time_frame>5 years</time_frame>
    <description>2. Secondary stroke prevention prescribed.&#xD;
Antithrombotics prescribed&#xD;
Swallowing evaluation performed before oral feeding starts&#xD;
DVT prophylaxis prescribed&#xD;
Anticoagulation for atrial fibrillation prescribed&#xD;
Brain imaging including vascular imaging performed&#xD;
Stroke education provided&#xD;
Educating patient to stop smoking&#xD;
Statins prescribed&#xD;
Rate of catheter related UTI&#xD;
Rate of aspiration pneumonia&#xD;
Hospital length of stay&#xD;
Discharge destination&#xD;
The time frame for this project is 5 years. All elements of acute stroke care will be collected during the hospital stay.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess the rate of antiplatelet agent used for stroke prevention.</measure>
    <time_frame>5 years</time_frame>
    <description>This would include the rate of patients being prescribed dual antiplatelet therapy, and the duration/compliance of taking antiplatelet medicine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the rate of using anticoagulant medication for stroke prevention in patients with atrial fibrillation.</measure>
    <time_frame>5 years</time_frame>
    <description>To assess the rate of bridging therapy used during hospitalization. Bridging therapy is to give intravenous or subcutaneous anticoagulation while waiting for warfarin to be therapeutic. In addition, the rate of prescribing new oral anticoagulants for stroke prevention in atrial fibrillation will be assessed,</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100000</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Acute Stroke patient</arm_group_label>
    <description>Patients who are presented to hospital within 7days from onset. The key measurement of clinical quality controlled in patients with acute stroke managment and inhouse stroke care were record automatically</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>stroke network and policy intervention</intervention_name>
    <description>Shanghai stroke service and network contributes to update the ability of stroke care of comprehensive and primary stroke center,to improve radiation ability of comprehensive stroke centers and try to form a close relationship between comprehensive stroke centers and its primary stroke centers.</description>
    <arm_group_label>Acute Stroke patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with acute stroke are admitted to these 11 hospital in Shanghai for secondary&#xD;
        prevention.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years old or older&#xD;
&#xD;
          -  primary diagnosis as acute stroke or TIA within 7 days from onset&#xD;
&#xD;
          -  admitted in stroke unit.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  child or teenager younger than 18 years old&#xD;
&#xD;
          -  woman with pregnant&#xD;
&#xD;
          -  outpatient&#xD;
&#xD;
          -  any other reason that patient cannot be admitted for secondary prevention&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiang Dong, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Stroke Service System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yi Dong, M.D</last_name>
    <phone>86-21-52887145</phone>
    <email>drdongyi@yeah.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kun Fang, M.D</last_name>
    <phone>86-21-52887146</phone>
    <email>drfrankhs@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongshan Hospital affiliated to Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xin Wang, M.D.,Ph.D.</last_name>
      <phone>13501909896</phone>
      <email>wang.xin@zs-hospital.sh.cn</email>
    </contact>
    <investigator>
      <last_name>Xin Wang, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Huashan Hospital，Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiang Dong, M.D., Ph.D.</last_name>
      <phone>86-13701875129</phone>
      <email>qiang_dong163@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Yi Dong, M.D.</last_name>
      <phone>86-13916665674</phone>
      <email>drdongyi@yeah.net</email>
    </contact_backup>
    <investigator>
      <last_name>Kun Fang, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yi Dong, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shuguang Hospital affiliated to Shanghai Traditional Chinese Medicine University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaofei Yu, M.D.，Ph.D.</last_name>
      <phone>13331978806</phone>
      <email>doctorxiaoyu@sina.com</email>
    </contact>
    <investigator>
      <last_name>Xiaofei Yu, M.D.，Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Shanghai Tenth People's Hospital, Tongji University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200072</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xueyuan Liu</last_name>
      <phone>13564578127</phone>
      <email>lxyshtj@163.com</email>
    </contact>
    <investigator>
      <last_name>Xueyuan Liu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dongfang Hospital affiliated to Shanghai University of TCM</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gang Li, M.D.</last_name>
      <phone>13621691786</phone>
      <email>ligang0531@yeah.net</email>
    </contact>
    <contact_backup>
      <last_name>Changsong Li</last_name>
      <phone>13122751682</phone>
      <email>kite1107@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Gang Li, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Renji hospital，Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yangtai Guan, Ph.D., M.D.</last_name>
      <phone>13386271865</phone>
      <email>yangtaiguan@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ying Chen</last_name>
      <phone>13501763660</phone>
      <email>13501763660@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yangtai Guan, Ph.D., M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benqiang Deng, M.D.</last_name>
      <phone>13701936570</phone>
      <email>13701936570@163.com</email>
    </contact>
    <investigator>
      <last_name>Benqiang Deng, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Changzheng Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shanghai Jiao Tong University School of Medicine Ruijin Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi Fu</last_name>
      <phone>86-021-64370045</phone>
      <email>fuyiki@sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Shufen Chen</last_name>
      <phone>1379532986</phone>
      <email>csf_cindy@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yi Fu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianren Liu, M.D.</last_name>
      <phone>liujr021@vip.163.com</phone>
      <email>liujr021@vip.163.com</email>
    </contact>
    <investigator>
      <last_name>Jianren Liu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Sixth People's Hospital affiliated to Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuwu Zhao, M.D.</last_name>
      <phone>15901713716</phone>
      <email>zhaoyuwu2005@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Hongmei Wang</last_name>
      <phone>18930177606</phone>
      <email>dd-tt12345@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yuwu Zhao, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>March 31, 2016</study_first_submitted>
  <study_first_submitted_qc>April 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Stroke Service System</investigator_affiliation>
    <investigator_full_name>Qiang Dong</investigator_full_name>
    <investigator_title>Director of Shanghai Stroke Service system</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>Shanghai Healthcare</keyword>
  <keyword>Healthcare Quality, Access, and Evaluation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data is planning to make individual participant data available, especially to anticipating collaborator.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

